Phase 1/2

PI: Jiayi Huang, MD

WU201901009 | NCT03604978
Study of Nivolumab plus or minus Ipilimumab in Combination with Multi-fraction Stereotactic Radiosurgery for Recurrent High-grade Radiation-relapsed Meningioma